SEK127 1.8 1.4%
Last Trade - 16/04/21
| Market Cap | £375.9m |
| Enterprise Value | £368.7m |
| Revenue | £8.99m |
| Position in Universe | 556th / 1831 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 46.1 | 51.8 | 57.3 | 65.7 | 101.5 | 104.8 | 181 | 236.5 | +17.8% | ||
| +15.1 | +101.3 | -0.10 | +145.8 | +47.9 | ||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Surgical Science Sweden AB is a Sweden-based company, which provides with virtual reality simulators for evidence based laparoscopic and endoscopic training. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Public Since | June 19, 2017 |
| No. of Shareholders: | 2,841 |
| No. of Employees: | 61 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | OMX Nordic Exchange Stockholm |
| Shares in Issue | 34,494,760 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Drakegatan 7 A 3 tr, GOETEBORG, 412 50, Sweden |
| Web | https://surgicalscience.com/ |
| Phone | +46 31 7416560 |
| Contact | () |
| Auditors | KPMG AB |
As of 16/04/21, shares in Surgical Science Sweden AB are trading at SEK127, giving the company a market capitalisation of £375.9m. This share price information is delayed by 15 minutes.
Shares in Surgical Science Sweden AB are currently trading at SEK127 and the price has moved by 0.120k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Surgical Science Sweden AB price has moved by 70.26% over the past year.
Of the analysts with advisory recommendations for Surgical Science Sweden AB, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Surgical Science Sweden AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Surgical Science Sweden AB is scheduled to issue upcoming financial results on the following dates:
Surgical Science Sweden AB does not currently pay a dividend.
Surgical Science Sweden AB does not currently pay a dividend.
Surgical Science Sweden AB does not currently pay a dividend.
To buy shares in Surgical Science Sweden AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Surgical Science Sweden AB are currently trading at SEK127, giving the company a market capitalisation of £375.9m.
Here are the trading details for Surgical Science Sweden AB:
Based on an overall assessment of its quality, value and momentum, Surgical Science Sweden AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Surgical Science Sweden AB are currently priced at SEK127. At that level they are trading at 18.11% discount to the analyst consensus target price of 0.00.
Analysts covering Surgical Science Sweden AB currently have a consensus Earnings Per Share (EPS) forecast of 1.065 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Surgical Science Sweden AB. Over the past six months, the relative strength of its shares against the market has been 9.08%. At the current price of SEK127, shares in Surgical Science Sweden AB are trading at 34.29% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Surgical Science Sweden AB PE ratio based on its reported earnings over the past 12 months is 0.293k. The shares are currently trading at SEK127.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We were unable to find the directors for Surgical Science Sweden AB.
Here are the top five shareholders of Surgical Science Sweden AB based on the size of their shareholding:
